FDA commissioner disputes Trump, says no ‘deep state’ elements delaying vaccine By Reuters

FDA commissioner disputes Trump, says no 'deep state' elements delaying

© Reuters. U.S. President Trump holds a news conference in Washington

By Jeff Mason

WASHINGTON (Reuters) – The U.S. Food and Drug Administration (FDA) is not made up of “deep state” elements that are trying to delay a coronavirus vaccine as President Donald Trump has suggested, the agency’s commissioner told Reuters on Monday.

Dr. Stephen Hahn said he was completely confident that the FDA’s workers were focused solely on the good of the American public.

Without evidence, Trump on Saturday accused members of the so-called “deep state” at the FDA of working to slow testing of COVID-19 vaccines until after the Nov. 3 presidential election.

“I have not seen anything that I would consider to be ‘deep state’ at the FDA,” Hahn told Reuters in an interview.

Hahn said had a solid relationship with Trump, a Republican whose re-election chances in November have been dampened by public discontent over his handling of the coronavirus pandemic.

“I enjoy a very good relationship with the president and I have discussed our decisions with him, and I feel very comfortable and continue to feel comfortable with that relationship,” Hahn said.

Hahn said a recent FDA decision to authorize a coronavirus treatment that uses blood plasma from recovered patients was not done because of political pressure, and he said he would not let such pressure influence a decision about a future COVID-19 vaccine.

“I will not participate in a decision at FDA that’s made upon anything other than data and science. That I can assure you,” he said.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

About us

InvestLab is a financial services technology company focused on the global trading market. Founded in 2010 in Hong Kong, the company develops trading, market data, and social research products that enable individual investors and small to mid-size brokers to access global markets. We provide brokers and financial institutions cross border capabilities for retail investors into 43 markets globally.